Development of standard clinical endpoints for use in dengue interventional trials
Dengue is a major public health problem worldwide. Although several drug candidates have been evaluated in randomized controlled trials, none has been effective and at present, early recognition of severe dengue and timely supportive care are used to reduce mortality. While the first dengue vaccine...
Principais autores: | Tomashek, K, Wills, B, See Lum, L, Thomas, L, Durbin, A, Leo, Y, De Bosch, N, Rojas, E, Hendrickx, K, Erpicum, M, Agulto, L, Jaenisch, T, Tissera, H, Suntarattiwong, P, Collers, B, Wallace, D, Schmidt, A, Precioso, A, Narvaez, F, Thomas, S, Edelman, R, Siqueira, J, Cassetti, M, Dempsey, W, Gubler, D |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Public Library of Science
2018
|
Registros relacionados
-
Development of standard clinical endpoints for use in dengue interventional trials
por: Tomashek, Kay M., et al.
Publicado em: (2018) -
Severe dengue categories as research endpoints—results from a prospective observational study in hospitalised dengue patients
por: Rosenberger, KD, et al.
Publicado em: (2020) -
Dogma in classifying dengue disease.
por: Farrar, J, et al.
Publicado em: (2013) -
Dogma in classifying dengue disease
por: Farrar, J, et al.
Publicado em: (2013) -
Helicopter EMS: Research Endpoints and Potential Benefits
por: Stephen H. Thomas, et al.
Publicado em: (2012-01-01)